JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Steven R. Meyer
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peskey, C. S.
Right arrow Articles by Abel, M. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Peskey, C. S.
Right arrow Articles by Abel, M. D.
Related Collections
Right arrow Anesthesia
Right arrow Cardiac - pharmacology
Right arrow Extracorporeal circulation

J Thorac Cardiovasc Surg 2009;138:491-492
© 2009 The American Association for Thoracic Surgery


Brief Clinical Report

Vasopressin withdrawal associated with massive polyuria

Candy S. Peskey, PharmDa, William J. Mauermann, MDb,*, Steven R. Meyer, MD, PhDc, Martin D. Abel, MDd

a Mayo Clinic Rochester Department of Pharmacy, Rochester, Minn
b Department of Anesthesiology, Division of Cardiovascular Anesthesiology, Mayo Clinic Rochester, Rochester, Minn
c Department of Cardiac Surgery, Division of Cardiovascular Surgery, Mayo Clinic Rochester, Rochester, Minn
d Department of Anesthesiology, Division of Cardiovascular Anesthesiology, Mayo Clinic Rochester, Rochester, Minn

Received for publication February 13, 2008; revisions received May 22, 2008; accepted for publication June 15, 2008.

* Address for reprints: William J. Mauermann, MD, 200 First St SW–Mb 2-752, Rochester, MN 55909. (Email: mauermann.william@mayo.edu).

The first 20% of the full text of this article appears below.


    Introduction
 
Vasopressin has demonstrated success in the treatment of vasodilatory shock.1Go It is also frequently used to manage decreased systemic vascular resistance (SVR) during or after cardiac surgery with cardiopulmonary bypass. We report a case of massive polyuria and increasing serum tonicity after withdrawal of a vasopressin infusion in a patient after cardiac surgery.


    Clinical Summary
 
A 32-year-old man with Marfan's syndrome treated with atenolol and lisinopril underwent repair of an ascending aortic aneurysm, closure of a patent foramen ovale, and mitral valve repair. After termination of cardiopulmonary bypass, a vasopressin infusion (0.08 U/min) was initiated for persistent hypotension caused by decreased SVR (456 dynes · sec–1 · cm–5). The vasopressin infusion was continued for 3 days, at which time the infusion was withdrawn over 12 hours. During this period, the patient was awake and alert and had free access to oral fluids.

Within 3 hours of discontinuing the vasopressin infusion, the patient's urine output increased to more than 1 L/h without any other medication changes, and oral fluid intake averaged 300 mL/h (Figure 1 ). Specifically, no diuretics had been administered for at least 24 hours. The serum sodium concentration (normal range, 135–145 mmol/L) increased to 135 mmol/L from 129 . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The American Association for Thoracic Surgery.